What do the two stocks represent in this comparison and why are their business models different?

Oscar Health (stock_1) focuses on health insurance platforms and technology-enabled plan distribution, while Radian Group (stock_2) operates as a mortgage insurer with a core focus on risk assessment and credit protection. The contrast highlights how a technology-led insurer and a financial services firm tied to housing markets approach revenue, profitability, and growth differently within their sectors.

How do profitability metrics differ between the two companies in this page?

Profitability is framed by distinct earnings signals: Oscar Health shows net losses and a negative price-to-earnings ratio, reflecting ongoing investments and growth costs. Radian demonstrates positive earnings with year-on-year growth, supported by stable cash flow from mortgage insurance. Interpreting these metrics requires considering each company’s lifecycle stage and cost structure.

What is price-to-earnings (P/E) and why does it matter in this comparison?

P/E compares share price to earnings per share, helping gauge relative valuation. Oscar Health’s negative P/E signals losses, while Radian’s lower but positive P/E may indicate more mature profitability. The contrast informs readers about how market expectations align with each company's earnings trajectory and risk profile.

What do the ‘pros’ and ‘cons’ indicate about growth prospects for each stock?

The pros highlight growth drivers: Oscar Health’s platform expansion and demand for flexible health insurance options, versus Radian’s profitable operations and steady dividend. The cons flag risks: Oscar Health’s losses and policy sensitivity, versus Radian’s housing-market exposure and potential earnings normalisation. Together, they outline potential volatility and resilience drivers.

How should an investor interpret volatility from sector sensitivity in this comparison?

Oscar Health faces policy and regulatory sensitivity that can swing margins and growth, suggesting higher policy risk. Radian’s results depend on the US housing cycle and interest rates, implying cyclical volatility. Investors should weigh macro factors and regulatory environments alongside company fundamentals when comparing these stocks.

What does dividend yield mean in the context of these two stocks?

Dividend yield reflects cash returns relative to share price. Radian’s stable cash flow supports a competitive yield, signposting income potential for some investors. Oscar Health, not noted for dividends in the context, may rely more on capital appreciation and growth funding, which influences risk versus reward considerations.

How do market contexts shape the outlook for Oscar Health and Radian?

Oscar Health operates in a growing health insurance segment with technology-enabled disruption potential, while Radian’s trajectory aligns with housing market strength and mortgage activity. Broader factors like policy shifts, interest rates, and housing demand will influence each stock’s risk and return profile in the medium term.

Why might analyst ratings differ between these two stocks?

Analysts may rate Oscar Health with caution due to ongoing losses and regulatory exposure, versus a Hold stance for Radian, reflecting steady fundamentals yet limited near-term upside. Ratings encapsulate earnings visibility, risk, and sector dynamics, rather than a sole focus on current price movements.

How should a beginner use this page to compare stocks without giving financial advice?

Treat the page as an educational guide highlighting how to read business models, profitability signals, and market factors. Compare revenue streams, cost structure, risk factors, and macro sensitivities. Use the information to inform your own research and decision-making process rather than relying on any single conclusion.

What is the educational disclaimer included in this comparison?

This page presents neutral, factual information about Oscar Health (stock_1) and Radian (stock_2), describing their models and market context. It does not constitute personalised investment advice, and readers should perform their own analysis and consult professionals before making any financial decisions.

Oscar Health vs Radian

Börsennotiertes Unternehmen vs US-Hypothekenversicherer zur Absicherung des Ausfallrisikos von Wohnungsbaudarlehen. Welche Aktie passt im September 2026 besser zu Ihrem Portfolio? Die Antwort in einfacher Sprache finden Sie unten.

Oscar Health is a tech-forward health insurer burning cash to acquire members and reshape the individual insurance market, while Radian is a mature mortgage insurance specialist that's been generating steady capital returns for years. Both companies are fundamentally insurance businesses whose fortunes hinge on the macroeconomic backdrop, whether that's healthcare costs or the housing credit cycle. Digging into Oscar Health vs Radian shows what growth-stage disruption looks like compared to a seasoned niche insurer playing defense on a shrinking addressable market.

Vergleich im Überblick

Wichtige Finanzkennzahlen

OSCR

Kennzahl

RDN

$10.11B

Marktkapitalisierung

$4.71B

-21.53%

Potenzieller Gewinn

-11.72%

Halten

Analystenbewertung

Kaufen

Weitere Vergleiche entdecken

Oscar Health vs Selective

Oscar Health bets its future on tech-driven health insurance for individuals while Selective Insurance has spent over a century quietly compounding in the commercial property-casualty market. Both operate within the broader insurance industry, but their risk profiles, customer bases, and growth trajectories are miles apart. The Oscar Health vs Selective comparison reveals which insurer delivers more compelling financials and whether Oscar's disruptive model can match Selective's proven underwriting discipline.

Oscar Health vs Upstart

Oscar Health sells individual and small-group health insurance plans powered by its own technology platform while Upstart uses AI to underwrite personal and auto loans at a pace that traditional lenders can't match, pairing two data-driven financial platforms that took very different paths through the rising-rate environment. Both companies raised capital aggressively during low-rate conditions and had to reckon sharply with investor skepticism when macro conditions shifted. Oscar Health vs Upstart lays out the loss ratio trends, unit economics evolution, and path to sustainable profitability that define whether either company's growth thesis has actually matured.

Oscar Health vs Lemonade

Oscar Health built a tech-forward health insurance platform targeting individual and small-group markets with a digital-first member experience, while Lemonade set out to reinvent property and casualty insurance with AI-driven claims processing and a B-Corp charitable giving model. Both are insurtech companies that raised enormous amounts of capital on the promise that technology could make insurance faster, cheaper, and less adversarial, yet both have faced hard questions about underwriting losses and the path to profitability. The Oscar Health vs Lemonade comparison puts two high-profile insurance disruptors side by side to see whose loss ratios, growth rates, and capital runway tell a more convincing story about eventual viability.

Anlageanalyse

Oscar Health

OSCR

Vorteile

Oscar Health has expanded its technology platform to support both direct health plans and third-party providers, enhancing its market reach.
The company operates in the growing individual and small group health insurance segment, benefiting from increased demand for flexible coverage options.
Oscar Health maintains a relatively low price-to-sales ratio compared to sector peers, suggesting potential undervaluation.

Zu beachten

Oscar Health continues to report net losses, reflected in its negative price-to-earnings ratio, raising concerns about profitability.
The stock faces significant downside risk as analyst targets suggest a potential decline from current levels.
The company's business model is highly sensitive to regulatory changes and healthcare policy shifts, which could impact margins and growth.

Radian

RDN

Vorteile

Radian Group demonstrates strong profitability with consistent year-on-year growth in both revenue and net income.
The company offers a competitive dividend yield, supported by a stable cash flow from its core mortgage insurance operations.
Radian's low price-to-earnings ratio suggests the stock may be attractively valued relative to its earnings performance.

Zu beachten

Radian's financial results are closely tied to the US housing market, exposing it to cyclical downturns and interest rate volatility.
Analysts have assigned a 'Hold' rating, indicating limited near-term upside potential despite solid fundamentals.
Future earnings could normalize as the mortgage insurance market matures and competition intensifies.

Über Oscar Health und Radian

Oscar Health (OSCR)

Oscar Health, Inc. is a healthcare technology company built around a full-stack technology platform. The Company serves individuals, families, and employees through the Patient Protection and Affordable Care Act (ACA). It also offers health technology solutions that power the healthcare industry through +Oscar. It also wholly owns three businesses operating in the individual market: Lucie, Inc., a technology enrollment platform for consumers, employers and brokers; Trove Group Inc., an insurance agency that sells individual medical and supplemental health products, and HealthInsurance.org, LLC, a lead generation website providing educational content to help consumers navigate health insurance as well as the ACA and Medicare marketplaces.

Radian (RDN)

Radian Group Inc. (RDN) ist ein in den USA ansässiger Anbieter von Hypothekenversicherungen und Immobiliendienstleistungen, der das Ausfallrisiko von Hypotheken absichert und damit verbundene Lösungen für das Risikomanagement anbietet. Anleger sollten wissen, dass Radians Erträge aus Prämieneinnahmen, Kapitalanlageerträgen auf das eingesetzte Kapital sowie aus der Fähigkeit des Unternehmens stammen, Schäden und Rückstellungen zu steuern. Das Geschäft profitiert tendenziell von stabilen oder steigenden Immobilienpreisen und einer starken Beschäftigungslage, da diese die Schadenquoten senken. Ein Abschwung am Immobilienmarkt oder eine Verschlechterung der Kreditwürdigkeit von Darlehensnehmern kann dagegen die Verluste erhöhen. Radian reagiert zudem empfindlich auf Zinsveränderungen, da diese die Vergabe neuer Hypotheken und die Refinanzierungsaktivität beeinflussen. Die Kapitalausstattung und aufsichtsrechtliche Kapitalanforderungen bestimmen, wie viel Neugeschäft der Konzern zeichnen kann und in welchem Umfang er Kapital an die Aktionäre zurückführt. Mit einer Marktkapitalisierung von etwa $4.6bn gehört Radian zum US-Finanzsektor im Mid-Cap-Segment. Die Aktie kann für Anleger interessant sein, die an der Entwicklung des Hypothekenfinanzierungszyklus partizipieren möchten. Ob sie zum jeweiligen Anleger passt, hängt jedoch von der Risikotoleranz, dem Anlagehorizont und dem Portfoliozusammenhang ab. Dies sind allgemeine Informationen und keine personalisierte Finanzberatung.

In welchen Aktienkörben sind sie enthalten?

Medicare Advantage Rate Hike Opportunities in 2026

The Centers for Medicare & Medicaid Services finalized a 2.48% payment increase for 2027, granting health insurers a surprise $13 billion funding boost. This collection features managed care organizations and healthcare providers poised to benefit from this highly favorable regulatory reversal.

Veröffentlicht: 10. April 2026

Aktienkorb entdecken

In welchen Aktienkörben sind sie enthalten?

Medicare Advantage Rate Hike Opportunities in 2026

Veröffentlicht: 10. April 2026

Aktienkorb entdecken

OSCR oder RDN in Nemo kaufen

🆓

Ohne Provision

Handeln Sie Aktien, ETFs und mehr ohne Provision. Behalten Sie mehr von Ihrer Rendite.

🔒

Vertrauenswürdig & reguliert

Seit 2015 Teil der Exinity Group, mit über einer Million Kunden weltweit.

💰

6 % Zinsen auf Guthaben

Erhalten Sie 6 % Zinsen p.a. auf nicht investiertes Guthaben, mit täglicher Zinsgutschrift.

Oscar Health vs Radian

Vergleich im Überblick